Related references
Note: Only part of the references are listed.Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study
Olivier Rouviere et al.
LANCET ONCOLOGY (2019)
Predicting Benign Prostate Pathology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Men with a Prior Negative 12-core Systematic Biopsy: External Validation of a Prognostic Nomogram
Marc A. Bjurlin et al.
EUROPEAN UROLOGY FOCUS (2019)
Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma
Susan Prendeville et al.
JOURNAL OF UROLOGY (2018)
A Comprehensive Analysis of Cribriform Morphology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy Correlated with Radical Prostatectomy Specimens
Matthew Truong et al.
JOURNAL OF UROLOGY (2018)
Multi-Institutional Nomogram Predicting Benign Prostate Pathology on Magnetic Resonance/Ultrasound Fusion Biopsy in Men With a Prior Negative 12-Core Systematic Biopsy
Matthew Truong et al.
CANCER (2018)
Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer
Charlotte F. Kweldam et al.
MODERN PATHOLOGY (2017)
In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
Simpa S. Salami et al.
BJU INTERNATIONAL (2015)
Share Paper
